Heron Therapeutics Gross Margin Growth & History (HRTX)

Heron Therapeutics's gross margin was 73.31% for fiscal 2025.

View full Heron Therapeutics company overview

Heron Therapeutics annual gross margin history

Heron Therapeutics annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20252025-12-3173.31%+0.09 pp
20242024-12-3173.21%+24.46 pp
20232023-12-3148.75%−0.28 pp
20222022-12-3149.04%

Heron Therapeutics gross margin trends

Across the available reported history, Heron Therapeutics's gross margin increased from 73.21% to 73.31%, a change of +0.09 percentage points. The latest reported quarter, Q2 2026, shows 69.28%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Heron Therapeutics filings at SEC.gov ↗